Are you joining the #CancerEquityColloquium this week (bit.ly/3HRpOcL)? Don't miss powerful and inspiring panels like this one 👉 'The Compounding Effects of Cancer: 'My Voice, My Story, My Truth.' Mike Moïse stanley rameau MadeINcubator Mass General Brigham Mass General Brigham Professional Development
Save the date for our #CancerEquityColloquium on April 21-22, 2023 at the Boston Marriott Cambridge. Presenters from a wide array of backgrounds will bring unique perspectives to topics related to cancer inequities. Stay tuned to learn more and register! Mass General Brigham Professional Development
Thrilled to be speaking at Mass General Cancer Center’s 2023 #CancerEquityColloquium in April! All are welcome to join this hybrid event in Boston as we tackle the diverse issues that underlie #cancerinequities . Learn more & save your seat: bit.ly/3iWzTN6 Mass General Brigham Professional Development
Thank you to everyone who participated in the 2023 #CancerEquityColloquium !
📸 Alex Joachim: Welcome reception Artists For Humanity where cancer patients, survivors, & family members shared their stories while being fashionably groomed w/ pieces from amazing black-owned local designers.
Clinical responsibilities of a first year attending got me missing out on this fantastic Mass General Cancer Center #CancerEquityColloquium .
Happily following along with all the 🔥🔥🔥posts from Dr. Karen Winkfield 𝖉𝖆𝖛𝖊 𝖋𝖚𝖑𝖑𝖊𝖗 @[email protected] Radiation Oncology | Dartmouth Cancer Center
#Intentionality #Collaborations #HereOnPurpose 💪🏽
Starting off the morning at Mass General Cancer Center #CancerEquityColloquium with Dr. Karen Winkfield “Improving Cancer Equity Through Precision Medicine”. Critically important point - it’s not just about the molecule.
The constant message from this amazing group of #pharma professionals???Collaboration is key!!
#CancerEquity is not a competitive space. We must move as one to move the needle.
Shout out to my #ASCO_LDP classmate Neelima Denduluri for representing. ASCO #CancerEquity Colloquium
MD/PhD student UMass Chan Medical School and non-profit founder (!) Kenley Preval turning our focus to the upstream portions of our leaky pipeline in academic medicine. A key step in equitable healthcare delivery is a diverse workforce. #CancerEquityColloquium
The #CancerEquityColloquium was an incredible experience for me. Hearing from patients and providers impacted by inequities in our systems, and their suggestions for how we can improve, is critical to changing the status quo. I'm inspired to #DoBetter 𝖉𝖆𝖛𝖊 𝖋𝖚𝖑𝖑𝖊𝖗 @[email protected] David "Bo" McClatchy, PhD
Moments after the #CancerEquityColloquium Mass General Cancer Center ended, rec’d word that my late husband’s #BFF died. Knew George (farR) was in the #ICU ; showed this photo at the end of my talk to honor him: Shown w/my late hubs JD (center) & the late great Dr. Tim George (farL). #RIP 🦋
I am leaving the #CancerEquityColloquium hosted by Dr. Colin Weekes informed, fulfilled, and empowered. We heard from the community, developed relationships with the community, because this is for the community. Mass General Cancer Center
Massey director Dr. Rob Winn will be at Mass General Cancer Center’s #CancerEquityColloquium in April! All are welcome to join this hybrid event in Boston as they tackle the diverse issues that underlie #cancerinequities . Learn more & save your seat: bit.ly/3iWzTN6 Mass General Brigham Professional Development
Spent the last 3 days engaged in tough convos around #inclusion #DEI & #healthequity . My final act was sitting down with Dr. Colin Weekes founder of the #CancerEquityColloquium to outline next steps.🔥🔥🔥
As always, I discussed the AAA: #Awareness ➡️ #Advocacy ➡️ #Action MVTCP CPACHE Program
Last chance to register for the #CancerEquityColloquium kicking off tomorrow! These are some of the impressive speakers we have lined up—we hope to see you there! bit.ly/3HRpOcL Mass General Brigham Mass General Brigham Professional Development
Xenetic Biosciences is a biopharmaceutical company focused on advancing proprietary technology platforms across multiple high-value cancer indications. Learn more about us here: bit.ly/3xixJIx
$XBIO #Oncology #SolidTumors #PancreaticCancer #CARTcells
Dr. Charles Thomas highlighting hypervisibility, one of the hardest aspects of the URM trainee experience, in his talk this morning “Sustained Mentorship: An Integral Component to Achieve Cancer Equity” #CancerEquityColloquium